| Product Code: ETC13182288 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Plaque Psoriasis Market was valued at USD 16 Billion in 2024 and is expected to reach USD 23 Billion by 2031, growing at a compound annual growth rate of 4.80% during the forecast period (2025-2031).
The Global Plaque Psoriasis Market is experiencing steady growth driven by factors such as increasing prevalence of plaque psoriasis, growing awareness about the condition, and advancements in treatment options. Biologics have emerged as a popular choice for managing plaque psoriasis due to their efficacy and targeted approach. Additionally, the market is witnessing a surge in research and development activities focused on developing novel therapies with improved outcomes and reduced side effects. Geographically, North America and Europe dominate the market due to high prevalence rates and favorable reimbursement policies. However, emerging economies in Asia-Pacific and Latin America are also presenting significant growth opportunities as healthcare infrastructure improves and awareness about the condition increases. Overall, the Global Plaque Psoriasis Market is poised for continued expansion in the coming years.
The Global Plaque Psoriasis Market is witnessing significant growth driven by the increasing prevalence of psoriasis worldwide. Biologics, such as TNF inhibitors and IL-17 inhibitors, are dominating the market due to their efficacy in managing moderate to severe plaque psoriasis. The market is also benefiting from the rising adoption of combination therapies and personalized treatment approaches. Additionally, the introduction of novel biologics and small molecule therapies, as well as the development of biosimilars, are creating opportunities for market expansion. Furthermore, telemedicine and digital health solutions are gaining traction for remote patient monitoring and treatment adherence, thereby enhancing patient care outcomes. Overall, the Global Plaque Psoriasis Market is poised for continued growth with advancements in treatment options and increasing awareness about the disease.
The Global Plaque Psoriasis Market faces several challenges, including limited treatment options for severe cases, high costs associated with biologic therapies, and the potential for adverse side effects from existing treatments. Patient adherence to treatment regimens can also be a challenge, as long-term management of plaque psoriasis requires consistent medication use and lifestyle modifications. Additionally, access to specialized healthcare providers and resources may be limited in certain regions, contributing to disparities in patient outcomes. Regulatory hurdles and uncertainties regarding the approval of new therapies further complicate the market landscape. Overall, addressing these challenges requires a multi-faceted approach involving healthcare providers, pharmaceutical companies, regulators, and patient advocacy groups to improve treatment options, access to care, and patient outcomes in the Global Plaque Psoriasis Market.
The Global Plaque Psoriasis Market is primarily driven by factors such as the increasing prevalence of psoriasis worldwide, growing awareness about the condition among patients and healthcare professionals, and the availability of advanced treatment options. The rising adoption of biologic therapies and targeted treatments, along with the development of innovative medications, are also fueling market growth. Additionally, the expanding geriatric population, lifestyle changes leading to higher incidence of psoriasis, and supportive government initiatives for better management of psoriasis are contributing to the market expansion. Furthermore, the continuous research and development activities focused on finding more effective and safer therapies for plaque psoriasis are expected to drive the market in the coming years.
Government policies related to the Global Plaque Psoriasis Market focus on ensuring access to affordable treatment options, promoting research and development for innovative therapies, and enhancing patient care and support services. Regulatory bodies such as the FDA in the United States and the EMA in Europe play a crucial role in approving new drugs for the treatment of plaque psoriasis, ensuring their safety and efficacy. Government initiatives also aim to increase awareness about the condition, reduce stigma, and improve healthcare infrastructure to better serve patients with plaque psoriasis. Additionally, policies may include provisions for insurance coverage and reimbursement for psoriasis treatments to make them more accessible to patients. Overall, government policies in the Global Plaque Psoriasis Market are geared towards improving outcomes for patients, advancing medical research, and addressing healthcare disparities.
The Global Plaque Psoriasis Market is anticipated to witness steady growth in the coming years due to increasing prevalence of psoriasis worldwide, rising awareness about treatment options, and advancements in biologic therapies. The market is expected to be driven by the introduction of innovative therapies with improved efficacy and safety profiles, as well as growing investments in research and development by pharmaceutical companies. Additionally, the expanding patient pool, particularly in emerging economies, and the availability of novel treatment options such as biosimilars are likely to further fuel market growth. However, challenges such as high treatment costs and stringent regulatory requirements may impede market expansion to some extent. Overall, the Global Plaque Psoriasis Market is projected to experience sustained growth driven by evolving treatment landscape and increasing focus on personalized medicine.
In the global plaque psoriasis market, Asia Pacific is expected to witness significant growth due to the increasing prevalence of psoriasis in countries like China and India. North America is a key market driven by advanced healthcare infrastructure and high awareness levels among patients. Europe is also a prominent market with a strong focus on research and development, leading to the introduction of innovative treatment options. The Middle East and Africa region is experiencing a rise in psoriasis cases, creating opportunities for market growth. Latin America is anticipated to show steady growth, supported by improving healthcare facilities and rising awareness about psoriasis treatments. Overall, the global plaque psoriasis market is poised for growth across all regions, driven by increasing disease prevalence and advancements in treatment options.
Global Plaque Psoriasis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Plaque Psoriasis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Plaque Psoriasis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Plaque Psoriasis Market - Industry Life Cycle |
3.4 Global Plaque Psoriasis Market - Porter's Five Forces |
3.5 Global Plaque Psoriasis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Plaque Psoriasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Global Plaque Psoriasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Plaque Psoriasis Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.9 Global Plaque Psoriasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Plaque Psoriasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Plaque Psoriasis Market Trends |
6 Global Plaque Psoriasis Market, 2021 - 2031 |
6.1 Global Plaque Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Plaque Psoriasis Market, Revenues & Volume, By Topical therapy, 2021 - 2031 |
6.1.3 Global Plaque Psoriasis Market, Revenues & Volume, By Phototherapy, 2021 - 2031 |
6.1.4 Global Plaque Psoriasis Market, Revenues & Volume, By Systemic agents, 2021 - 2031 |
6.1.5 Global Plaque Psoriasis Market, Revenues & Volume, By Biologic therapies, 2021 - 2031 |
6.1.6 Global Plaque Psoriasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Plaque Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Plaque Psoriasis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Plaque Psoriasis Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.3 Global Plaque Psoriasis Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Plaque Psoriasis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Plaque Psoriasis Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.3.4 Global Plaque Psoriasis Market, Revenues & Volume, By Speciality centres, 2021 - 2031 |
6.3.5 Global Plaque Psoriasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Plaque Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Plaque Psoriasis Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.4.3 Global Plaque Psoriasis Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.4.4 Global Plaque Psoriasis Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 North America Plaque Psoriasis Market, Overview & Analysis |
7.1 North America Plaque Psoriasis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Plaque Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Plaque Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Plaque Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Plaque Psoriasis Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.6 North America Plaque Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Plaque Psoriasis Market, Overview & Analysis |
8.1 Latin America (LATAM) Plaque Psoriasis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Plaque Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Plaque Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.4 Latin America (LATAM) Plaque Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Plaque Psoriasis Market, Revenues & Volume, By End Use, 2021 - 2031 |
8.6 Latin America (LATAM) Plaque Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Plaque Psoriasis Market, Overview & Analysis |
9.1 Asia Plaque Psoriasis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Plaque Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Plaque Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.4 Asia Plaque Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Plaque Psoriasis Market, Revenues & Volume, By End Use, 2021 - 2031 |
9.6 Asia Plaque Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Plaque Psoriasis Market, Overview & Analysis |
10.1 Africa Plaque Psoriasis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Plaque Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Plaque Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.4 Africa Plaque Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Plaque Psoriasis Market, Revenues & Volume, By End Use, 2021 - 2031 |
10.6 Africa Plaque Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Plaque Psoriasis Market, Overview & Analysis |
11.1 Europe Plaque Psoriasis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Plaque Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Plaque Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.4 Europe Plaque Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Plaque Psoriasis Market, Revenues & Volume, By End Use, 2021 - 2031 |
11.6 Europe Plaque Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Plaque Psoriasis Market, Overview & Analysis |
12.1 Middle East Plaque Psoriasis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Plaque Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Plaque Psoriasis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Plaque Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.4 Middle East Plaque Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Plaque Psoriasis Market, Revenues & Volume, By End Use, 2021 - 2031 |
12.6 Middle East Plaque Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Plaque Psoriasis Market Key Performance Indicators |
14 Global Plaque Psoriasis Market - Export/Import By Countries Assessment |
15 Global Plaque Psoriasis Market - Opportunity Assessment |
15.1 Global Plaque Psoriasis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Plaque Psoriasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.3 Global Plaque Psoriasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Plaque Psoriasis Market Opportunity Assessment, By End Use, 2021 & 2031F |
15.5 Global Plaque Psoriasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Plaque Psoriasis Market - Competitive Landscape |
16.1 Global Plaque Psoriasis Market Revenue Share, By Companies, 2024 |
16.2 Global Plaque Psoriasis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here